Publication | Closed Access

Nonhypotensive dose of β-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure

HypertensionHeart FailureCardiovascular PharmacologyRenal FunctionChronic Kidney DiseaseRenal PharmacologyCardiorenal Syndromesβ-Adrenergic BlockerVascular PharmacologyVascular BiologyRenal PathophysiologyDiuretic ResistancePharmacologyCardiovascular DiseaseModerate Renal FailurePhysiologyMedicineCapillary DeficitsNephrology